Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02802241 · ClinicalTrials.gov registry record · NA
Effects of Open-label vs Double-blind Treatment in IBS
A NA study of Irritable Bowel Syndrome and Placebo Effect, sponsored by Beth Israel Deaconess Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 340
- Enrollment target
- 1
- Study location
NCT02802241 is a NA study of Irritable Bowel Syndrome and Placebo Effect that has completed, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 340 participants, above the 137-participant average among 47 other Irritable Bowel Syndrome trials with a reported enrollment target (148% higher). The trial reports 1 study location across 1 state.
The verdict
NCT02802241, a NA study of Irritable Bowel Syndrome and Placebo Effect, has completed, sponsored by Beth Israel Deaconess Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 340 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to investigate placebo effects and peppermint oil in Irritable Bowel Syndrome.
Conditions Studied
Interventions
- DRUG placebo
- DIETARY_SUPPLEMENT peppermint oil
Study Locations (1)
Massachusetts
- Beth Israel Deaconess Medical Center - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 340 participants |
| Start Date | 2016-06 |
| Est. Completion | 2019-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02802241
The ClinicalTrials.gov registry entry for NCT02802241 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 340 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 137-participant average among 47 other Irritable Bowel Syndrome trials with a reported enrollment target (148% higher). The listed sponsor is Beth Israel Deaconess Medical Center, which has 488 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Irritable Bowel Syndrome appearing as the primary indexed condition, and to 2 interventions - of which placebo is the first listed.
NCT02802241 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT02802241 about?
NCT02802241 is a clinical study titled "Effects of Open-label vs Double-blind Treatment in IBS". The purpose of this study is to investigate placebo effects and peppermint oil in Irritable Bowel Syndrome.
What is the current status of trial NCT02802241?
This trial is currently completed. It is a NA study. The enrollment target is 340 participants. The study started on 2016-06. Estimated completion is 2019-01.
What conditions does trial NCT02802241 study?
This clinical trial studies the following conditions: Irritable Bowel Syndrome, Placebo Effect, Placebos, Peppermint Oil.
What interventions are being tested in trial NCT02802241?
The interventions under investigation include: placebo (DRUG), peppermint oil (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02802241?
This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02802241 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Irritable Bowel Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Do Biomarkers Predict Response to a Pediatric Chronic Pain Symptom Management Program?
RECRUITING · NA
-
GI Alpha-Gal Study
RECRUITING · NA
-
Visible Abdominal Distension
RECRUITING · NA
-
IBS Skin Patch Test Food Allergy Study
RECRUITING · NA
-
Standardized Yoga & Meditation Program for Stress Reduction for Adolescents With Irritable Bowel Syndrome
RECRUITING · NA
-
Well-being in IBS: Strengths and Happiness (WISH) 2.0
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.